Voyager Therapeuticsincis A Clinical Stage Biotechnology Company Based In Lexingtonmassachusettsfounded In 2013The Company Specializes In Developing Gene Therapies And Neurogenetic Medicines Aimed At Treating Severe Neurological Diseasesvoyager Went Public In 2015 And Currently Employs Around 172 Peopleits Mission Is To Create Disease Modifying Treatments By Targeting Validated Genetic Pathways And Enhancing Delivery To The Central Nervous System The Company Focuses On Various Neurological Conditionsincluding Alzheimerae S Diseasealsfriedreichae S Ataxiaparkinsonae S Diseaseand Huntingtonae S Diseasevoyager Employs Innovative Modalities Such As Gene Therapyvectorized Antibodiesand Rna Interference To Tackle These Diseasesits Proprietary Tracera C Platform Generates Aav Vectors That Improve Tissue Specificity And Blood Brain Barrier Penetrationsupporting Both Internal Programs And Strategic Partnerships With Major Companies Like Neurocrine Biosciencesnovartisand Pfizervoyager Is Committed To Advancing Therapies That Address Critical Unmet Needs In Neurogenetic Medicine
No conferences found for this company.
| Company Name | Voyager Pharmaceutical Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
